Exhibit II
to
Schedule 13G
Joint Filing Agreement
The undersigned persons agree and consent to the joint filing on their behalf of this Schedule 13G dated September 10, 2021 in connection with their beneficial ownership of Eiger BioPharmaceuticals, Inc. Each of Columbia Seligman Technology and Information Fund and Columbia Management Investment Advisers, LLC authorizes Ameriprise Financial, Inc. to execute the Schedule 13G to which this Exhibit is attached and make any necessary amendments thereto.
Ameriprise Financial, Inc. | ||
By: | /s/ Paul Goucher | |
Name: Paul Goucher | ||
Title: Senior Vice President and Assistant General Counsel | ||
Columbia Management Investment Advisers, LLC | ||
By: | /s/ Paul Goucher | |
Name: Paul Goucher | ||
Title: Senior Vice President and Assistant Secretary | ||
Columbia Seligman Technology and Information Fund | ||
By: | /s/ Paul Goucher | |
Name: Paul Goucher | ||
Title: Senior Vice President and Assistant Secretary |